Literature DB >> 11870008

Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen Project.

Katie Palmer1, Hui-Xin Wang, Lars Bäckman, Bengt Winblad, Laura Fratiglioni.   

Abstract

OBJECTIVE: This study was a prospective, population-based examination of the evolution of cognitive impairment, no dementia (CIND).
METHOD: Subjects 75 years old or older living in Stockholm were assessed at baseline and 3 and 6 years later. The severity of CIND was based on age- and education-specific norms on the Mini-Mental State Examination and was classified as mild (N=212), moderate (N=96), or severe (N=57). Mortality, progression to dementia (DSM-III-R), cognitive stability, and cognitive improvement were studied as main outcomes.
RESULTS: Of the individuals with mild CIND, 63 (34%) died, 65 (35%) progressed to dementia, 21 (11%) remained stable, and 46 (25%) improved between baseline and first follow-up. The relative risks of progressing to dementia by first follow-up in the subjects with mild, moderate, and severe CIND were 3.6, 5.4, and 7.0, respectively. The relative risk of death decreased with increasing severity of impairment. Individuals who improved at first follow-up did not have a significantly higher risk of later progressing to dementia than subjects who had never been impaired (relative risk=1.4). The absence of a subjective memory complaint predicted improvement (odds ratio=5.4).
CONCLUSIONS: CIND is a heterogeneous condition: similar proportions of subjects progress to dementia, death, and cognitive improvement over 3 years. There is no increased future risk of progressing to dementia in CIND subjects who improve during that period.

Entities:  

Mesh:

Year:  2002        PMID: 11870008     DOI: 10.1176/appi.ajp.159.3.436

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  46 in total

Review 1.  Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease.

Authors:  F Portet; P J Ousset; P J Visser; G B Frisoni; F Nobili; Ph Scheltens; B Vellas; J Touchon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-20       Impact factor: 10.154

2.  Outcomes of older cognitively impaired individuals with current and past depression in the NCODE study.

Authors:  David C Steffens; Douglas R McQuoid; Guy G Potter
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-02-04       Impact factor: 2.680

3.  Does cognition predict mortality in midlife? Results from the Whitehall II cohort study.

Authors:  Séverine Sabia; Alice Guéguen; Michael G Marmot; Martin J Shipley; Joël Ankri; Archana Singh-Manoux
Journal:  Neurobiol Aging       Date:  2008-06-09       Impact factor: 4.673

4.  MRI predictors of cognitive change in a diverse and carefully characterized elderly population.

Authors:  Owen Carmichael; Dan Mungas; Laurel Beckett; Danielle Harvey; Sarah Tomaszewski Farias; Bruce Reed; John Olichney; Joshua Miller; Charles Decarli
Journal:  Neurobiol Aging       Date:  2010-04-01       Impact factor: 4.673

5.  Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts.

Authors:  Sarah Tomaszewski Farias; Dan Mungas; Bruce R Reed; Danielle Harvey; Charles DeCarli
Journal:  Arch Neurol       Date:  2009-09

6.  Heterogeneity of cognitive trajectories in diverse older persons.

Authors:  Dan Mungas; Laurel Beckett; Danielle Harvey; Sarah Tomaszewski Farias; Bruce Reed; Owen Carmichael; John Olichney; Joshua Miller; Charles DeCarli
Journal:  Psychol Aging       Date:  2010-09

7.  Mild cognitive impairment: a concept in evolution.

Authors:  R C Petersen; B Caracciolo; C Brayne; S Gauthier; V Jelic; L Fratiglioni
Journal:  J Intern Med       Date:  2014-03       Impact factor: 8.989

Review 8.  The Role of Hypoxia-Inducible Factor 1 in Mild Cognitive Impairment.

Authors:  Osigbemhe Iyalomhe; Sabina Swierczek; Ngozi Enwerem; Yuanxiu Chen; Monica O Adedeji; Joanne Allard; Oyonumo Ntekim; Sheree Johnson; Kakra Hughes; Philip Kurian; Thomas O Obisesan
Journal:  Cell Mol Neurobiol       Date:  2016-11-17       Impact factor: 5.046

9.  Brain atrophy associated with baseline and longitudinal measures of cognition.

Authors:  V A Cardenas; L L Chao; C Studholme; K Yaffe; B L Miller; C Madison; S T Buckley; D Mungas; N Schuff; M W Weiner
Journal:  Neurobiol Aging       Date:  2009-05-14       Impact factor: 4.673

10.  Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.

Authors:  Marta Encinas; Ramón De Juan; Alberto Marcos; Pedro Gil; Ana Barabash; Cristina Fernández; Carmen De Ugarte; José Antonio Cabranes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-08-15       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.